Study to Evaluate the Effect of Xolair(Omalizumab) on Improving the Tolerability of Specific Immunotherapy in Patients With at Least Moderate Persistent Allergic Asthma Inadequately Controlled With Inhaled Corticosteroids
This study has been completed.
Sponsor:
University of Mississippi Medical Center
Collaborator:
Novartis
Information provided by:
University of Mississippi Medical Center
ClinicalTrials.gov Identifier:
NCT00691873
First received: June 3, 2008
Last updated: June 5, 2008
Last verified: January 2007
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | October 2007 |
| Primary Completion Date: | May 2007 (Final data collection date for primary outcome measure) |